Swiss pharma company pays $5.5 bn for US capsule maker
Thursday, December 15, 2016 - 04:21
in Mathematics & Economics
Swiss pharmaceuticals and life sciences group Lonza said Thursday it had bought US capsule maker Capsugel for $5.5 billion as it focuses more on health care.